Government Ban On 344 Drugs
- All
- News
-
You Can Now Buy Vicks Action 500, Corex As Delhi Court Cancels Ban
Delhi High Court stayed on Thursday a government ban on 344 drugs that it deemed lacked therapeutic efficacy, after over six months of hearing more than 300 petitions filed by drugmakers against it.
-
Pharma Sector May Post Good Growth in Q4: Centrum Broking
The pharma sector is expected to report good growth for the fourth quarter of 2015-16 despite regulatory concerns raised by US Food and Drug Administration (FDA) and the recent ban on 344 fixed dose combinations imposed by the government, a report by Centrum Broking said.
-
FDC Drugs Banned Over Safety And Efficacy Concerns: Centre To Court
Government on Thursday told Delhi High Court that the decision to ban 344 fixed dose combination (FDC) drugs was taken keeping in view "safety, efficacy and rationality" of these medicines.
-
Drug Ban: Delhi High Court To Hear Plea Of Pharma Companies
In what could be the Maggi moment for the pharma majors, the Delhi High Court will today hear cases filed by various pharmaceutical companies against a ban imposed by the central government on 344 drug combinations.
-
Corex, Popular Cough Syrup, Not Banned For Now, Says Court
The High Court will hear the case in a week. The ban on Pfizer's cough syrup was part of a wider notice issued by the government over the weekend prohibiting the sale and manufacture of 344 combination drugs blacklisted by a panel of experts.
-
High Court Grants Interim Stay On Stopping Sale Of Corex Cough Syrup
The ban on Pfizer's cough syrup was part of a wider notice issued by the government over the weekend ordering prohibition of the sale and manufacture of 344 combination drugs that a panel of experts found posed a risk to humans.
-
You Can Now Buy Vicks Action 500, Corex As Delhi Court Cancels Ban
Delhi High Court stayed on Thursday a government ban on 344 drugs that it deemed lacked therapeutic efficacy, after over six months of hearing more than 300 petitions filed by drugmakers against it.
-
Pharma Sector May Post Good Growth in Q4: Centrum Broking
The pharma sector is expected to report good growth for the fourth quarter of 2015-16 despite regulatory concerns raised by US Food and Drug Administration (FDA) and the recent ban on 344 fixed dose combinations imposed by the government, a report by Centrum Broking said.
-
FDC Drugs Banned Over Safety And Efficacy Concerns: Centre To Court
Government on Thursday told Delhi High Court that the decision to ban 344 fixed dose combination (FDC) drugs was taken keeping in view "safety, efficacy and rationality" of these medicines.
-
Drug Ban: Delhi High Court To Hear Plea Of Pharma Companies
In what could be the Maggi moment for the pharma majors, the Delhi High Court will today hear cases filed by various pharmaceutical companies against a ban imposed by the central government on 344 drug combinations.
-
Corex, Popular Cough Syrup, Not Banned For Now, Says Court
The High Court will hear the case in a week. The ban on Pfizer's cough syrup was part of a wider notice issued by the government over the weekend prohibiting the sale and manufacture of 344 combination drugs blacklisted by a panel of experts.
-
High Court Grants Interim Stay On Stopping Sale Of Corex Cough Syrup
The ban on Pfizer's cough syrup was part of a wider notice issued by the government over the weekend ordering prohibition of the sale and manufacture of 344 combination drugs that a panel of experts found posed a risk to humans.
